Evidence map›Paper›PMID 39819717›Full record

ArticleNan fang yi ke da xue xue bao = Journal of Southern Medical University2025

Quercetin mediates the therapeutic effect of

Qing Liu, Jing Liu, Yihang Zheng, Jin Lei, Jianhua Huang, Siyu Liu, Fang Liu, Qunlong Peng, Yuanfang Zhang, Junjie Wang and 1 more

Abstract read
In one paragraph

Article in Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Evaluation ofPlants (Basel, Switzerland) · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Qing LiuCollege of Pharmacy, Xiangnan University, Chenzhou 423000, China.
Jing LiuCollege of Pharmacy, Xiangnan University, Chenzhou 423000, China.
Yihang ZhengCollege of Pharmacy, Xiangnan University, Chenzhou 423000, China.
Jin LeiCollege of Basic Medical Sciences, Xiangnan University, Chenzhou 423000, China.
Jianhua HuangCollege of Pharmacy, Xiangnan University, Chenzhou 423000, China.
Siyu LiuCollege of Pharmacy, Xiangnan University, Chenzhou 423000, China.
Fang LiuCollege of Pharmacy, Xiangnan University, Chenzhou 423000, China.
Qunlong PengCollege of Pharmacy, Xiangnan University, Chenzhou 423000, China.
Yuanfang ZhangCollege of Pharmacy, Xiangnan University, Chenzhou 423000, China.
Junjie WangCollege of Pharmacy, Xiangnan University, Chenzhou 423000, China.
Yujuan LiCollege of Basic Medical Sciences, Xiangnan University, Chenzhou 423000, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo explore the active components that mediate the therapeutic effect of

methodsTCMSP, TCMIP, PharmMapper, Swiss Target Prediction, GeneCards, OMIM and TTD databases were searched for the compounds in

resultsA total of 139 targets of

conclusionsQuercetin, asiaticoside and asiatic acid are the main active components in

Indexed as

PsoriasisQuercetinSTAT3 Transcription FactorTriterpenesAnimalsCentellaInterleukin-17Interleukin-23MacrophagesMicePentacyclic TriterpenesPhosphorylationPlant ExtractsRAW 264.7 CellsSignal Transductionasiatic acidasiaticosideCentella asiatica extractInterleukin-17Interleukin-23Pentacyclic TriterpenesPlant ExtractsQuercetinStat3 protein, mouseSTAT3 Transcription FactorTriterpenesCentella asiaticaIL-23/IL-17Anetwork pharmacologypsoriasisquercetin

Identifiers

PMID39819717
PMCPMC11744291

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.